Estimation of the Tissue and Serum Levels of Interleukin (IL) -35 in Mycosis Fungoides: a Case Control Study

Cairo University20 enrolled

Overview

Tissue and serum samples from 20 MF patients and 20 normal healthy controls will be subjected for biochemical assessments by ELISA (Enzyme- linked immune-sorbent assay) for assessing the level of IL35.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Mycosis Fungoides

Interventions

Skin biopsyDIAGNOSTIC_TEST

biochemical assessment for measurement IL35 by ELISA (Enzyme linked immunosorbent assay) technique in tissue and serum samples of all thirty patients and healthy controls.

Eligibility

Sex: ALLMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with mycosis fungoides. Both genders. Age group ≥ 18 years old. Exclusion Criteria: * Patients with any other skin diseases. Patients who received treatments for mycosis fungoides in the past three months. Subjects with history of solid or hematological malignancy as leukemia

Locations (1)

Cairo University

Giza, Egypt

RECRUITING

Outcomes

Primary Outcomes

To assess and compare tissue and serum levels of interleukin 35 (IL -35) in mycosis fungoides patients and normal controls.

Time frame: 1 year

Secondary Outcomes

Correlating tissue and serum levels of IL-35 in mycosis fungoides patients with patients age, sex, duration, extent and stage of the disease. L

Correlating tissue and serum levels of IL-35 in mycosis fungoides patients with patients age, sex, duration, extent and stage of the disease.

Time frame: 1 year

Central Contacts

Sally Doss, MD

CONTACT

01223283288 Sallydoss@hotmail.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.